par Kaye, S B;Wanders, Jantien;Clavel, Michel;Verweij, Jaap;Piccart-Gebhart, Martine 
;Smyth, J F;ten Bokkel Huinink, Wim;Wagener, Th;Judson, I R;Cavalli, F
Référence Annals of oncology, 3, 5, page (406-408)
Publication Publié, 1992-05
;Smyth, J F;ten Bokkel Huinink, Wim;Wagener, Th;Judson, I R;Cavalli, FRéférence Annals of oncology, 3, 5, page (406-408)
Publication Publié, 1992-05
Article révisé par les pairs
| Titre: |
|
| Auteur: | Kaye, S B; Wanders, Jantien; Clavel, Michel; Verweij, Jaap; Piccart-Gebhart, Martine; Smyth, J F; ten Bokkel Huinink, Wim; Wagener, Th; Judson, I R; Cavalli, F |
| Informations sur la publication: | Annals of oncology, 3, 5, page (406-408) |
| Statut de publication: | Publié, 1992-05 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Breast |
| Fosquidone | |
| Head and neck | |
| Melanomas | |
| Ovary | |
| Phase II | |
| MeSH keywords: | Adult |
| Aged | |
| Antineoplastic Agents -- adverse effects | |
| Antineoplastic Agents -- therapeutic use | |
| Breast Neoplasms -- drug therapy | |
| Drug Evaluation | |
| Female | |
| Head and Neck Neoplasms -- drug therapy | |
| Humans | |
| Isoquinolines -- adverse effects | |
| Isoquinolines -- therapeutic use | |
| Male | |
| Melanoma -- drug therapy | |
| Middle Aged | |
| Organophosphorus Compounds -- adverse effects | |
| Organophosphorus Compounds -- therapeutic use | |
| Ovarian Neoplasms -- drug therapy | |
| Note générale: | Clinical Trial |
| Journal Article | |
| Multicenter Study | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0923-7534 |
| info:scp/0026548884 | |
| info:pmid/1616895 |
